Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026
Go back to Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 75.35 +2.63 (3.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $72.72 | 52 Week High | $13.18 | |||
| Open | $72.39 | 52 Week Low | $6.00 | |||
| Day High | $76.81 | P/E | N/A | |||
| Day Low | $72.39 | EPS | $-1.24 | |||
| Volume | 1,920,980 | |||||
